Aclarion, Inc. (ACON) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $3.17. It has a SharesGrow Score of 45/100, indicating a mixed investment profile with 3 out of 7 criteria passed.
Valuation: ACON trades at a trailing Price-to-Earnings (P/E) of -0.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.03.
Financials: revenue is $75,730, +17%/yr average growth. Net income is $7M (loss), growing at +0.1%/yr. Net profit margin is -9551.9% (negative). Gross margin is -291.3% (-283.3 pp trend).
Balance sheet: total debt is $0 against $12.8T equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 14.81 (strong liquidity). Debt-to-assets is 0%. Total assets: $13.7T.
Analyst outlook: 1 / 2 analysts rate ACON as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 63/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 0/100 (Fail), Future 40/100 (Partial), Income 10/100 (Fail).
